Financial - Capital Markets
Compare Stocks
2 / 10Stock Comparison
LAZ vs HLI
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
LAZ vs HLI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Financial - Capital Markets | Financial - Capital Markets |
| Market Cap | $4.24B | $10.31B |
| Revenue (TTM) | $3.19B | $2.39B |
| Net Income (TTM) | $237M | $448M |
| Gross Margin | 31.8% | 38.5% |
| Operating Margin | 13.0% | 21.0% |
| Forward P/E | 14.1x | 19.5x |
| Total Debt | $2.58B | $438M |
| Cash & Equiv. | $1.50B | $971M |
LAZ vs HLI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Lazard Ltd (LAZ) | 100 | 167.9 | +67.9% |
| Houlihan Lokey, Inc. (HLI) | 100 | 248.3 | +148.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LAZ vs HLI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LAZ is the clearest fit if your priority is defensive.
- Beta 1.79, yield 3.9%, current ratio 29.35x
- Lower P/E (14.1x vs 19.5x)
- 3.9% yield, 1-year raise streak, vs HLI's 1.6%
HLI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 7 yrs, beta 0.94, yield 1.6%
- Rev growth 24.8%, EPS growth 41.6%
- 6.0% 10Y total return vs LAZ's 94.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 24.8% NII/revenue growth vs LAZ's 3.2% | |
| Value | Lower P/E (14.1x vs 19.5x) | |
| Quality / Margins | Efficiency ratio 0.2% vs LAZ's 0.2% (lower = leaner) | |
| Stability / Safety | Beta 0.94 vs LAZ's 1.79, lower leverage | |
| Dividends | 3.9% yield, 1-year raise streak, vs HLI's 1.6% | |
| Momentum (1Y) | +16.3% vs HLI's -7.1% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs LAZ's 0.2% |
LAZ vs HLI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
LAZ vs HLI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HLI leads this category, winning 5 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
LAZ and HLI operate at a comparable scale, with $3.2B and $2.4B in trailing revenue. HLI is the more profitable business, keeping 16.7% of every revenue dollar as net income compared to LAZ's 7.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.2B | $2.4B |
| EBITDAEarnings before interest/tax | $384M | $591M |
| Net IncomeAfter-tax profit | $237M | $448M |
| Free Cash FlowCash after capex | $519M | $739M |
| Gross MarginGross profit ÷ Revenue | +31.8% | +38.5% |
| Operating MarginEBIT ÷ Revenue | +13.0% | +21.0% |
| Net MarginNet income ÷ Revenue | +7.4% | +16.7% |
| FCF MarginFCF ÷ Revenue | +15.9% | +33.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -43.8% | +22.3% |
Valuation Metrics
LAZ leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 20.8x trailing earnings, LAZ trades at a 19% valuation discount to HLI's 25.8x P/E. On an enterprise value basis, LAZ's 11.8x EV/EBITDA is more attractive than HLI's 18.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $4.2B | $10.3B |
| Enterprise ValueMkt cap + debt − cash | $5.3B | $9.8B |
| Trailing P/EPrice ÷ TTM EPS | 20.78x | 25.80x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.10x | 19.50x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.64x |
| EV / EBITDAEnterprise value multiple | 11.81x | 18.01x |
| Price / SalesMarket cap ÷ Revenue | 1.33x | 4.32x |
| Price / BookPrice ÷ Book value/share | 4.85x | 4.74x |
| Price / FCFMarket cap ÷ FCF | 8.38x | 12.75x |
Profitability & Efficiency
HLI leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
LAZ delivers a 26.7% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $20 for HLI. HLI carries lower financial leverage with a 0.20x debt-to-equity ratio, signaling a more conservative balance sheet compared to LAZ's 2.61x. On the Piotroski fundamental quality scale (0–9), HLI scores 7/9 vs LAZ's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +26.7% | +19.5% |
| ROA (TTM)Return on assets | +5.2% | +11.4% |
| ROICReturn on invested capital | +9.5% | +15.5% |
| ROCEReturn on capital employed | +9.5% | +20.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 2.61x | 0.20x |
| Net DebtTotal debt minus cash | $1.1B | -$533M |
| Cash & Equiv.Liquid assets | $1.5B | $971M |
| Total DebtShort + long-term debt | $2.6B | $438M |
| Interest CoverageEBIT ÷ Interest expense | 4.74x | — |
Total Returns (Dividends Reinvested)
HLI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HLI five years ago would be worth $24,223 today (with dividends reinvested), compared to $11,940 for LAZ. Over the past 12 months, LAZ leads with a +16.3% total return vs HLI's -7.1%. The 3-year compound annual growth rate (CAGR) favors HLI at 21.6% vs LAZ's 21.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -8.3% | -14.5% |
| 1-Year ReturnPast 12 months | +16.3% | -7.1% |
| 3-Year ReturnCumulative with dividends | +76.9% | +79.9% |
| 5-Year ReturnCumulative with dividends | +19.4% | +142.2% |
| 10-Year ReturnCumulative with dividends | +94.5% | +599.6% |
| CAGR (3Y)Annualised 3-year return | +21.0% | +21.6% |
Risk & Volatility
Evenly matched — LAZ and HLI each lead in 1 of 2 comparable metrics.
Risk & Volatility
HLI is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than LAZ's 1.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LAZ currently trades 76.8% from its 52-week high vs HLI's 70.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.79x | 0.94x |
| 52-Week HighHighest price in past year | $58.75 | $211.78 |
| 52-Week LowLowest price in past year | $38.67 | $134.41 |
| % of 52W HighCurrent price vs 52-week peak | +76.8% | +70.9% |
| RSI (14)Momentum oscillator 0–100 | 41.7 | 42.0 |
| Avg Volume (50D)Average daily shares traded | 1.5M | 562K |
Analyst Outlook
Evenly matched — LAZ and HLI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates LAZ as "Buy" and HLI as "Buy". Consensus price targets imply 33.2% upside for HLI (target: $200) vs 4.9% for LAZ (target: $47). For income investors, LAZ offers the higher dividend yield at 3.89% vs HLI's 1.60%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $47.33 | $200.00 |
| # AnalystsCovering analysts | 29 | 15 |
| Dividend YieldAnnual dividend ÷ price | +3.9% | +1.6% |
| Dividend StreakConsecutive years of raises | 1 | 7 |
| Dividend / ShareAnnual DPS | $1.75 | $2.41 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +0.5% |
HLI leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LAZ leads in 1 (Valuation Metrics). 2 tied.
LAZ vs HLI: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is LAZ or HLI a better buy right now?
For growth investors, Houlihan Lokey, Inc.
(HLI) is the stronger pick with 24. 8% revenue growth year-over-year, versus 3. 2% for Lazard Ltd (LAZ). Lazard Ltd (LAZ) offers the better valuation at 20. 8x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate Lazard Ltd (LAZ) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — LAZ or HLI?
On trailing P/E, Lazard Ltd (LAZ) is the cheapest at 20.
8x versus Houlihan Lokey, Inc. at 25. 8x. On forward P/E, Lazard Ltd is actually cheaper at 14. 1x.
03Which is the better long-term investment — LAZ or HLI?
Over the past 5 years, Houlihan Lokey, Inc.
(HLI) delivered a total return of +142. 2%, compared to +19. 4% for Lazard Ltd (LAZ). Over 10 years, the gap is even starker: HLI returned +599. 6% versus LAZ's +94. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — LAZ or HLI?
By beta (market sensitivity over 5 years), Houlihan Lokey, Inc.
(HLI) is the lower-risk stock at 0. 94β versus Lazard Ltd's 1. 79β — meaning LAZ is approximately 91% more volatile than HLI relative to the S&P 500. On balance sheet safety, Houlihan Lokey, Inc. (HLI) carries a lower debt/equity ratio of 20% versus 3% for Lazard Ltd — giving it more financial flexibility in a downturn.
05Which is growing faster — LAZ or HLI?
By revenue growth (latest reported year), Houlihan Lokey, Inc.
(HLI) is pulling ahead at 24. 8% versus 3. 2% for Lazard Ltd (LAZ). On earnings-per-share growth, the picture is similar: Houlihan Lokey, Inc. grew EPS 41. 6% year-over-year, compared to -19. 0% for Lazard Ltd. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — LAZ or HLI?
Houlihan Lokey, Inc.
(HLI) is the more profitable company, earning 16. 7% net margin versus 7. 4% for Lazard Ltd — meaning it keeps 16. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLI leads at 21. 0% versus 13. 0% for LAZ. At the gross margin level — before operating expenses — HLI leads at 38. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is LAZ or HLI more undervalued right now?
On forward earnings alone, Lazard Ltd (LAZ) trades at 14.
1x forward P/E versus 19. 5x for Houlihan Lokey, Inc. — 5. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLI: 33. 2% to $200. 00.
08Which pays a better dividend — LAZ or HLI?
All stocks in this comparison pay dividends.
Lazard Ltd (LAZ) offers the highest yield at 3. 9%, versus 1. 6% for Houlihan Lokey, Inc. (HLI).
09Is LAZ or HLI better for a retirement portfolio?
For long-horizon retirement investors, Houlihan Lokey, Inc.
(HLI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 6% yield, +599. 6% 10Y return). Lazard Ltd (LAZ) carries a higher beta of 1. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HLI: +599. 6%, LAZ: +94. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between LAZ and HLI?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: LAZ is a small-cap income-oriented stock; HLI is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.